PFE

10:32 am Pfizer announces positive Phase 2 study results for investigational meningococcal B vaccine; bivalent rLP2086 was observed to generate bactericidal responses against diverse meningococcal serogroup B test strains following either t

moreView todays social media effects on PFEView the latest stocks trending across Twitter. Click to view dashboardSee who Pfizer is hiring next, click here to view […]

Pfizer Announces Positive Phase 2 Study Results for Investigational Meningococcal B Vaccine

[Business Wire] – Pfizer Inc. announced today the results from two Phase 2 studies of bivalent rLP2086, Pfizer’s recombinant vaccine candidate, currently under development for the prevention of invasive meningococcal disease caused by Neisseria meningiti moreView todays social media effects on PFEView the latest stocks trending across Twitter. Click to view dashboardSee who Pfizer is hiring next, click here to […]